Business Context and Reporting Period
Company: Prestige Brands Holdings, Inc. (Prestige Consumer Healthcare Inc.)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three and nine months ended December 31, 2009
Business Overview: The Company markets, sells, and distributes over-the-counter healthcare, personal care, and household cleaning brands to mass merchandisers, drug stores, and supermarkets primarily in the United States and Canada. The Company operates through three segments: Over-the-Counter Healthcare, Household Cleaning, and Personal Care.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Dec 31, 2009 | Nine Months Ended Dec 31, 2009 |
|---|---|---|
| Total Revenues | $75,448 | $230,641 |
| Net Income | $10,580 | $28,828 |
| Operating Income | $23,701 | $63,457 |
| Gross Profit Margin | 52.8% | 52.9% |
| Net Cash from Operating Activities | N/A | $50,490 |
| Cash and Cash Equivalents (Dec 31, 2009) | $34,262 | |
| Total Debt (Long-term + Current) | $319,337 | |
| Diluted EPS | $0.21 | $0.58 |
Material Changes vs. Prior Period
- Revenue: Total revenues decreased 3.2% for the three months ended Dec 31, 2009, compared to the prior year, and decreased 1.6% for the nine-month period. The Household Cleaning segment saw the most significant decline (6.2% for nine months), while the Personal Care segment grew 13.3%.
- Profitability: Net income increased 32% for the three months and 18.5% for the nine months compared to the prior year periods. This improvement was driven primarily by a 46.3% reduction in advertising and promotional spending, which offset declines in gross profit.
- Discontinued Operations: In October 2009, the Company sold assets related to its shampoo brands (Personal Care segment). This resulted in a net gain of $157,000 on the sale and the reclassification of related results as discontinued operations.
- Debt Reduction: The Company repaid $56.3 million of indebtedness in excess of normal maturities during the nine-month period, reducing total outstanding debt from $378.3 million (March 31, 2009) to $319.3 million (December 31, 2009).
- Intangible Assets: $45.6 million of previously indefinite-lived intangible assets were reclassified to finite-lived assets with a 20-year useful life, increasing amortization expense.
Guidance, Outlook, and Risks
- Customer Concentration Risk: In early February 2010, the Company's largest customer notified them of an intent to discontinue sales of "The Doctor's NightGuard" and "The Doctor's Brushpicks" (OTC Healthcare segment). These products generated approximately $2.1 million in revenue and $1.0 million in gross profit during the quarter ended Dec 31, 2009. The Company is seeking a review but cannot assure a reversal of this decision.
- Liquidity and Refinancing: The Company's revolving credit facility expired in April 2009. Management expects to refinance the existing Term Loan Facility and Senior Subordinated Notes on or before March 31, 2010. However, due to uncertain credit markets, there is no assurance that refinancing will be consummated or on favorable terms.
- Legal Proceedings: A securities class action lawsuit was settled in December 2009 with costs covered by insurance. Litigation with DenTek Oral Care, Inc. regarding intellectual property reached a tentative settlement in principle in January 2010, but a final agreement had not been executed as of the filing date.
- Forward-Looking Statements: The Company cautions that future results may differ due to economic conditions, competition, vendor rationalization, and the ability to protect intellectual property.
Investor Verification Checklist
- Customer Retention: Verify the status of the largest customer's decision regarding "The Doctor's" products and the potential impact on future OTC Healthcare revenue.
- Debt Refinancing: Monitor the Company's ability to refinance the $193.3 million Term Loan (maturing April 2011) and $126.0 million Senior Subordinated Notes (maturing April 2012) given current credit market conditions.
- Legal Settlements: Confirm the execution of the final settlement agreement with DenTek Oral Care, Inc. and any associated costs.
- Inventory Valuation: Review the allowance for obsolete and slow-moving inventory, which increased to $2.6 million (7.0% of total inventory) as of December 31, 2009.
- Intangible Asset Amortization: Assess the impact of the $45.6 million reclassification of indefinite-lived intangibles to finite-lived assets on future operating margins.